| Code | 4740C | ||||||||||
| MA number | EU/1/17/1197/001 | ||||||||||
| Product Form: | int opo 7x1 ml/20 µg (liek.skl.-viacdávk.) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU Orphan | ||||||||||
| MAH, country: | Dompé farmaceutici S.p.A., Italy | ||||||||||
| Therapeutic Class: | 64 - OPHTHALMOLOGICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | glass container | ||||||||||
| Route of admin.: | Ocular use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 06.07.2017 |
| SmPC + PL: |
European Medicines Agency's database
|
| Safety feature | Yes |
| Data update: | 20.04.2022 |
